Krystal Biotech, Inc. ($KRYS)
Filing Information
| Accession Number | 0001801385-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 3, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
39,369
Total Value
$1,165,991.28
P&L
+inf% (+$4,702,143.42)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Accounting Officer | Common Stock | โ | Feb 27, 2026 | Exercise/Conversion | 7,500 | $0.00 | $0.00 | 26,068 | Direct | โ | View Details | |
Chief Accounting Officer | Common Stock | โ | Feb 27, 2026 | Tax Withholding | 3,262 | $275.64 | $899,137.68 | 22,806 | Direct | โ | View Details | |
Chief Accounting Officer | Common Stock | โ | Feb 27, 2026 | Exercise/Conversion | 550 | $0.00 | $0.00 | 23,356 | Direct | โ | View Details | |
Chief Accounting Officer | Common Stock | โ | Feb 27, 2026 | Tax Withholding | 240 | $275.64 | $66,153.60 | 23,116 | Direct | โ | View Details | |
Chief Accounting Officer | Common Stock | โ | Mar 2, 2026 | Sale | 750 | $267.60 | $200,700.00 | 22,366 | Direct | โ | View Details | |
Chief Accounting Officer | Performance Stock Units | Derivative | Feb 27, 2026 | Exercise/Conversion | 7,500 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Chief Accounting Officer | Restricted Stock Units | Derivative | Feb 27, 2026 | Exercise/Conversion | 550 | $0.00 | $0.00 | 1,650 | Direct | โ | View Details | |
Chief Accounting Officer | Stock Option (Right to Buy) | Derivative | Feb 27, 2026 | Grant/Award | 13,575 | $0.00 | $0.00 | 13,575 | Direct | โ | View Details | |
Chief Accounting Officer | Restricted Stock Units | Derivative | Feb 27, 2026 | Grant/Award | 5,442 | $0.00 | $0.00 | 5,442 | Direct | โ | View Details |